Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / Regulation, ethics review and informed consent

Informed consent that is genuinely informed

14 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • List the essential elements of an informed consent form

  • Describe a good consent conversation, including with people who cannot read

  • Handle consent for children, assent and re-consent

Informed consent is a process in which a person freely agrees to participate after understanding what is involved. The signed form is evidence of the process, not the process itself.

Essential elements of the information

  • That the study involves research, its purpose and expected duration.
  • The procedures, including those that are experimental, and the chance of being assigned to each group (for example, randomisation).
  • Foreseeable risks and discomforts, including to an embryo, foetus or breastfed baby where relevant.
  • Expected benefits, and a statement that there may be none.
  • Alternatives to participation.
  • Confidentiality and who may see records (monitors, auditors, regulators, ethics committees).
  • Compensation and treatment for study-related injury.
  • Costs and payments (reimbursement for travel, not an inducement).
  • That participation is voluntary and that the person may withdraw at any time without penalty or loss of usual care.
  • Contact persons for questions and for complaints, including the REC.
  • New information that may affect willingness to continue will be shared.
1ExplainLocal language,plain words2CheckunderstandingAsk them toexplain it back3Time todecideDiscuss withfamily4Sign orthumbprintWith witness ifneeded5Copy andfollow-upGive copy,re-check
Consent is a conversation, not a signature.

A good consent conversation

  • Use a private, quiet space and a trained person who is not in a position of power over the participant (for example, not the treating clinician when this could pressure the person).
  • Speak in the language the person understands and avoid jargon. Use pictures, teach-back and examples.
  • Check understanding by asking open questions, such as "Can you tell me in your own words what will happen at the visits?" and "What would you do if you decided to stop?".
  • Allow time and the chance to consult family.
  • Where the person cannot read, an impartial witness attends the whole conversation, confirms that the information was accurately explained, and signs. The participant gives a thumbprint or mark.
  • Therapeutic misconception must be addressed: participants may believe the experimental treatment is certain to help.

Children, assent and capacity

  • Parental or guardian permission is required for children, and age-appropriate assent is sought from the child. Local law and ethics committees define the ages and rules. A child's refusal should be respected unless the intervention offers direct benefit not otherwise available.
  • Adults with reduced capacity need a legally authorised representative and additional safeguards.
  • Re-consent is needed when new risks emerge, the protocol changes materially, or a child reaches the age of consent.

Worked example: a consent conversation with a woman who cannot read

A woman attends an antenatal clinic and is invited to join a trial of a new malaria preventive medicine in pregnancy.

  • A trained study nurse, not her usual clinic nurse, explains in Luganda using a picture booklet.
  • The nurse invites her to bring her husband or a relative if she wishes. An impartial witness, a community member not linked to the study, attends.
  • The nurse asks, "What is the study trying to find out?" and "Will your clinic care change if you say no?" to check understanding.
  • She asks to discuss at home. She returns the next day and agrees. She gives a thumbprint, and the witness signs.
  • She receives a copy and the number of a contact person.

The study documents the process in a consent note in her file, including the time given to decide.

Weak consentStrong consentForm read quicklySigned on the spotClinician who treats her asksJargon and no questionsTeach-back usedTime to decideIndependent, trained staffPlain words, witness if needed
The same form can be used well or badly. The process decides whether the consent is real.

Voluntariness matters as much as understanding

People may feel unable to refuse a doctor, a nurse, or a service they depend on. Make clear that refusing will not affect care, and take care that payments or free services do not become undue inducements.

Never use consent forms as protection for the sponsor

Long legal language that participants cannot understand defeats the purpose. Keep forms readable and move technical detail to a separate information sheet if allowed.

Check yourself

Read your consent form aloud to a colleague who does not work in research. Where do they stumble or ask questions? Revise those parts.

Summary

  • Informed consent is a process of explanation, understanding and voluntary agreement, evidenced by a document.

  • Essential elements include purpose, procedures, risks, benefits, alternatives, confidentiality, compensation, voluntariness and contacts.

  • Teach-back, time to decide and an impartial witness for non-readers strengthen consent.

  • Children need parental permission and assent; re-consent is required when new information arises.

Check your understanding

Question 1
1

An impartial witness is present to:

Question 2
2

Teach-back in consent means:

Question 3
3

A participant may withdraw from a study:

Question 4
4

Therapeutic misconception is when participants:

Question 5
5

Re-consent is required when:

Question 6
6

Payments to participants should:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Regulatory and ethics approvals in Uganda and the regionVulnerability, data protection and community engagement